As of December 2024, Shanghai RAAS Blood Products has a market cap of $6.59B. This makes Shanghai RAAS Blood Products the world's 2171th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $6.28B | -13.87% |
2023 | $7.30B | 26.18% |
2022 | $5.78B | -7.04% |
2021 | $6.22B | -7.84% |
2020 | $6.75B | -0.27% |
2019 | $6.77B | -7.37% |
2018 | $7.31B | -59.65% |
2017 | $18.11B | -14.03% |
2016 | $21.06B | 4.51% |
2015 | $20.15B | 76.32% |
2014 | $11.43B | 89.94% |
2013 | $6.02B | 248.75% |
2012 | $1.73B | 2.41% |
2011 | $1.68B | -30.89% |
2010 | $2.44B | 58.81% |
2009 | $1.54B | 47.03% |
2008 | $1.04B | - |